Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rare Neoplastic Syndrome”

253 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 253 results

Not applicableLooking for participantsNCT07072143
What this trial is testing

An International Study on Pediatric Patients With Rare Tumors.

Who this might be right for
Paraganglioma/ PhaeochromocytomaMelanoma and Other Malignant Neoplasms of SkinGastrointestinal Stromal Tumor (GIST)+11 more
Azienda Ospedaliera di Padova 6,250
Testing effectiveness (Phase 2)UnknownNCT04553887
What this trial is testing

Almonertinib as Upfront Treatment for Uncommon EGFR Mutation Harboring Non-Small-Cell Lung Cancer Patients: A Multicenter, Open-Label, Phase II Trial

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 53
Not applicableUnknownNCT04137718
What this trial is testing

Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene Mutation

Who this might be right for
ChineseNon-Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 50,000
Not applicableStudy completedNCT00007046
What this trial is testing

Genetic Study of Patients and Families With Diaphyseal Medullary Stenosis With Malignant Fibrous Histiocytoma of the Bone

Who this might be right for
StenosisHistiocytoma
National Center for Research Resources (NCRR)
Not applicableLooking for participantsNCT04777175
What this trial is testing

A Retrospective Study: Evaluation of the Efficacy of Immunotherapy With Rare Mutations in Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Yongchang Zhang 186
Testing effectiveness (Phase 2)Active Not RecruitingNCT03264131
What this trial is testing

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

Who this might be right for
LymphomaAdult T-Cell Leukemia/LymphomaLymphatic Diseases
UNC Lineberger Comprehensive Cancer Center 16
Not applicableLooking for participantsNCT05046444
What this trial is testing

Solving Riddles Through Sequencing

Who this might be right for
LeukemiaHematologic MalignancyRare Diseases+3 more
Munich Leukemia Laboratory 100
Testing effectiveness (Phase 2)UnknownNCT05548348
What this trial is testing

First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon Mutation

Who this might be right for
Non-small Cell Lung CancerEGFR G719XEGFR L861Q+1 more
Chongqing University Cancer Hospital 30
Not applicableLooking for participantsNCT02834884
What this trial is testing

SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access

Who this might be right for
All Tumor Types
European Organisation for Research and Treatment of Cancer - EORTC 4,975
Testing effectiveness (Phase 2)Active Not RecruitingNCT06638931
What this trial is testing

Agnostic Therapy in Rare Solid Tumors

Who this might be right for
Urachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more
Instituto do Cancer do Estado de São Paulo 28
Large-scale testing (Phase 3)Study completedNCT00014742
What this trial is testing

Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease

Who this might be right for
Dupuytren's Contracture
State University of New York 72
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Not applicableNot Yet RecruitingNCT07125105
What this trial is testing

Integrating Art Therapy and Adapted Physical Activity: Toward Improved Quality of Life in Patients With Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Universite du Littoral Cote d'Opale 102
Not applicableNot Yet RecruitingNCT05985941
What this trial is testing

Prospective Multi-omics Observational Study of Gynecological Rare Pathological Tumors

Who this might be right for
Rare Gynecological TumorsMulti-omics Analysis
RenJi Hospital 600
Testing effectiveness (Phase 2)Study completedNCT02879162
What this trial is testing

Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours

Who this might be right for
Advanced Rare Tumours
Canadian Cancer Trials Group 140
Not applicableStudy completedNCT00005654
What this trial is testing

Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome

Who this might be right for
HyperinsulinismPolycystic Ovary Syndrome
National Center for Research Resources (NCRR) 88
Not applicableLooking for participantsNCT06796751
What this trial is testing

PREcision Diagnostics in Rare genetIC Diseases and Tumors - Long Read Sequencing

Who this might be right for
Whole Exome SequencingRare Diseases
IRCCS Azienda Ospedaliero-Universitaria di Bologna 30
Not applicableUnknownNCT04921553
What this trial is testing

Real Word European Registry of NTRK Fusions and Other Rare Actionable Fusions (TRacKING)

Who this might be right for
CancerCancer MetastaticNTRK Gene Fusion Overexpression+13 more
Centre Leon Berard 500
Not applicableLooking for participantsNCT05852522
What this trial is testing

Molecularly Aided Stratification for Tumor Eradication Research

Who this might be right for
Rare CancersMultiomics
German Cancer Research Center 10,000
Testing effectiveness (Phase 2)Looking for participantsNCT05872204
What this trial is testing

Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer

Who this might be right for
Low Grade Serous Ovarian CarcinomaAdult Type Granulosa Cell Tumor
Universitaire Ziekenhuizen KU Leuven 100
Load More Results